Sort
23,748 grants matching “melanoma”
Overcoming resistance to anti-PD1 immunotherapy
$946,072Thomas F Gajewski · University Of Chicago · R35 · FY2018 · CA
Defining the Importance of Immunity to NY-ESO-1 in Melanoma Therapy and Prognosis
$945,556Jedd D. Wolchok · Sloan-Kettering Inst Can Research · RC2 · FY2010 · CA
A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions
$944,492David L Hachey · Frontier Diagnostics, Llc · R44 · FY2020 · CA
Zebrafish core
$944,416Christine Kettenhofen · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$943,503James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$943,457William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Overcoming resistance to anti-PD1 immunotherapy
$943,344Thomas F Gajewski · University Of Chicago · R35 · FY2021 · CA
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$941,406William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Overcoming resistance to anti-PD1 immunotherapy
$941,158Thomas F Gajewski · University Of Chicago · R35 · FY2017 · CA
Illinois Oncology Research Association CCOP
$938,655John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2008 · CA
Evolution of Primary and Resistant Solid Tumors
$938,035Ronald Anthony Depinho · Dana-Farber Cancer Inst · U01 · FY2006 · CA
Determining the Fate of Transmembrane Proteins
$937,490Allan M Weissman · Basic Sciences · Z01 · FY2007 · CA
Clinical production of viral vectors for cancer gene therapy
$936,788Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Integrated, Individualized, Intelligent Prescribing (I3P)
$936,331Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2017 · HG
Next Generation Cancer Immunotherapies to Defeat Melanoma
$936,000Antoni Ribas · University Of California Los Angeles · R35 · FY2022 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$936,000Antoni Ribas · University Of California Los Angeles · R35 · FY2025 · CA
PREDICTION AND MODIFICATION OF MELANOMA RISK
$935,007University Of Pennsylvania · P01 · FY2000 · CA
Genetic Epidemiology
$934,721Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
$934,220Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Vanderbilt Clinical Oncology Research Career Development Award
$934,031Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2020 · CA
Quantitative Biophotonics for Tissue Characterization and Function
$933,110Amir H Gandjbakhche · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Using gene expression profiles to elucidate mechanisms of melanoma progression
$932,378Ashani Weeraratna · Aging · Z01 · FY2007 · AG
Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni
$932,044David E Kleiner · Clinical Sciences · Z01 · FY2007 · CA
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
$931,980Boris C Bastian · University Of California, San Francisco · R35 · FY2022 · CA
CLUE STUDIES--EVALUATING BIOMARKERS OF CARCINOGENESIS
$930,585Johns Hopkins University · U01 · FY2004 · CA